drugset / Trial / NCT05541497

Varenicline for Treatment of E-cigarette Dependence

NCT05541497

Phase 2 Completed 40 enrolled Yale University
RandomizedParallel-groupDouble-blindTreatment

Summary

Varenicline is used to treat tobacco use dependence. It helps reduce cravings for tobacco use and decreases the pleasurable effects of cigarettes and other tobacco products. Varenicline has been proven to reduce the desire to smoke cigarettes. This study aims to test whether it shows a similar benefit for individuals who vape and are interested in quitting.

Timeline

Start
2022-11-04
Primary completion
2023-09-01
Completion
2023-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Varenicline Small molecule 1 mg

Indications

No indication recorded.